Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Overexpression of the transcription factor Spi-1/PU.1 in mice leads to acute erythroleukemia characterized by a differentiation block at the proerythroblastic stage. In this study, we made use of a new cellular system allowing us to reach graded expression of Spi-1 in preleukemic cells to dissect mechanisms of Spi-1/ PU-1 in erythroleukemogenesis. This system is based on conditional production of 1 or 2 spi-1-interfering RNAs stably inserted into spi-1 transgenic proerythroblasts. We show that Spi-1 knock-down was sufficient to reinstate the erythroid differentiation program. This differentiation process was associated with an exit from the cell cycle. Evidence is provided that in the presence of erythropoietin (Epo), Spi-1 displays an antiapoptotic role that is independent of its function in blocking erythroid differentiation. Apoptosis inhibited by Spi-1 did not involve activation of the Fas/FasL signaling pathway nor a failure to activate Epo receptor (EpoR). Furthermore, we found that reducing the Spi-1 level yields to ERK dephosphorylation and increased phosphorylation of AKT and STAT5, suggesting that Spi-1 may affect major signaling pathways downstream of the EpoR in erythroid cells. These findings reveal 2 distinct roles for Spi-1 during erythroleukemogenesis: Spi-1 blocks the erythroid differentiation program and acts to impair apoptotic death in cooperation with an Epo signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We previously showed that constitutive overexpression of the oncogenic transcription factor Spi1/PU.1 leads to pre-leukemic cells that have a shortened S phase duration with an increased replication fork speed and increased mutability in the absence of DNA breaks.”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [9]
In the citing paper
“Maintaining elevated expression of SPI1 in mice leads to blockage of erythroid differentiation and favours survival of erythroid progenitors, initiating the erythroleukaemic process (17,23,24).”
From HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia (2022) · cites this paper as [24]
In the citing paper
“We previously showed in the spi-1 transgenic mice that Spi-1 overexpression in erythroleukemic progenitors induces differentiation arrest, apoptosis resistance and replication acceleration (18,19).”
From Spi-1/PU.1 activates transcription through clustered DNA occupancy in erythroleukemia (2012) · cites this paper as [18]
Citations
Cites
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Regulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749
Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice
Socolovsky, M., Fallon, A. E. J., Wang, S., Brugnara, C., & Lodish, H. F. (1999) · Cell · doi:10.1016/s0092-8674(00)81013-2 · Cited by 696
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
van de Wetering, M., Oving, I., Muncan, V., Pon Fong, M. T., Brantjes, H., van Leenen, D., Holstege, F. C., Brummelkamp, T. R., Agami, R., & Clevers, H. (2003) · EMBO reports · doi:10.1038/sj.embor.embor865 · Cited by 512
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506
Nocka, K., Majumder, S., Chabot, B., Ray, P., Cervone, M., Bernstein, A., & Besmer, P. (1989) · Genes & Development · doi:10.1101/gad.3.6.816 · Cited by 474
Rekhtman, N., Radparvar, F., Evans, T., & Skoultchi, A. I. (1999) · Genes & Development · doi:10.1101/gad.13.11.1398 · Cited by 454
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias
Moreau-Gachelin, F., Tavitian, A., & Tambourin, P. (1988) · Nature · doi:10.1038/331277a0 · Cited by 447
Self-citationIwasaki, H., Somoza, C., Shigematsu, H., Duprez, E. A., Iwasaki-Arai, J., Mizuno, S.-I., Arinobu, Y., Geary, K., Zhang, P., Dayaram, T., et al. (2005) · Blood · doi:10.1182/blood-2005-03-0860 · Cited by 433
Cited by
Kassouf, M. T., Hughes, J. R., Taylor, S., McGowan, S. J., Soneji, S., Green, A. L., Vyas, P., & Porcher, C. (2010) · Genome Research · doi:10.1101/gr.104935.110 · Cited by 177
EKLF restricts megakaryocytic differentiation at the benefit of erythrocytic differentiation
Bouilloux, F., Juban, G., Cohet, N., Selimoglu‐Buet, D., Guyot, B., Vainchenker, W., Louache, F., & Morlé, F. (2008) · Blood · doi:10.1182/blood-2007-07-098996 · Cited by 108
miR-155: A Novel Target in Allergic Asthma
Zhou, H., Li, J., Gao, P., Wang, Q., & Zhang, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101773 · Cited by 80
“1 contributes to erythropoiesis and hematopoiesis [35,36], and CEBPB suppresses leukemia pathogenesis through the inhibition of proliferation [37].”
BackgroundFagnan, A., Bagger, F. O., Piqué‐Borràs, M., Ignacimouttou, C., Caulier, A., Lopez, C. K., Robert, E., Uzan, B., Gelsi‐Boyer, V., Aid, Z., et al. (2020) · Blood · doi:10.1182/blood.2019003062 · Cited by 63
Wontakal, S. N., Guo, X., Will, B., Shi, M., Raha, D., Mahajan, M. C., Weissman, S., Snyder, M., Steidl, U., Zheng, D., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001392 · Cited by 53
“1 has been reported to promote proliferation of both erythroid progenitors [10,43] and bone marrow derived macrophages [73].”
Background
Metadata
- Authors
- Rimmelé, P., Kosmider, O., Mayeux, P., Moreau-Gachelin, F., & Guillouf, C.
- Affiliations
- Institut Curie, Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 528, Paris, France;
- Inserm (FR)
- Institut Cochin (FR)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2006-11-28
- Volume
- 109
- Issue
- 7
- Pages
- 3007-3014
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1982658542
- Cited by
- 35
- References
- 53
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 6 · 2020: 2 · 2017: 2 · 2016: 1 · 2014: 1 · 2013: 1 · 2012: 4
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- erythroleukemia, apoptosis inhibition, erythropoietin signaling, erythropoietin receptor, proerythroblasts, RNA knockdown, ERK dephosphorylation, Akt phosphorylation, STAT5, Fas/FasL signaling, cell cycle exit, transcription factor overexpression
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, Base Sequence, Cell Cycle, Cell Differentiation, Erythroblasts, Leukemia, Erythroblastic, Acute, Erythropoiesis, Erythropoietin, Humans, Mice, Transgenic, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Apoptosis, Receptors, Erythropoietin, RNA, Small Interfering, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation. https://app.cochat.ai/papers/10.1182/blood-2006-03-006718
- The paper
- Rimmelé, P., Kosmider, O., Mayeux, P., Moreau-Gachelin, F., & Guillouf, C. (2007). Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation. Blood. https://doi.org/10.1182/blood-2006-03-006718
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.